These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23150076)

  • 21. Identification of molecular targets of the oligomeric nonprenylated acylphloroglucinols from Myrtus communis and their implication as anti-inflammatory compounds.
    Feisst C; Franke L; Appendino G; Werz O
    J Pharmacol Exp Ther; 2005 Oct; 315(1):389-96. PubMed ID: 16014754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New inhibitors of ROS generation and T-cell proliferation from Myrtus communis.
    Choudhary MI; Khan N; Ahmad M; Yousuf S; Fun HK; Soomro S; Asif M; Mesaik MA; Shaheen F
    Org Lett; 2013 Apr; 15(8):1862-5. PubMed ID: 23550772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant activity of oligomeric acylphloroglucinols from Myrtus communis L.
    Rosa A; Deiana M; Casu V; Corona G; Appendino G; Bianchi F; Ballero M; Dessì MA
    Free Radic Res; 2003 Sep; 37(9):1013-9. PubMed ID: 14670009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
    Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
    Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
    Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW
    J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of Myrtacine® and its potential value in acne treatment.
    Fiorini-Puybaret C; Aries MF; Fabre B; Mamatas S; Luc J; Degouy A; Ambonati M; Mejean C; Poli F
    Planta Med; 2011 Sep; 77(14):1582-9. PubMed ID: 21452108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
    Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presystemic metabolism of AZ'0908, a novel mPGES-1 inhibitor: an in vitro and in vivo cross-species comparison.
    Bylund J; Bueters T
    J Pharm Sci; 2013 Mar; 102(3):1106-15. PubMed ID: 23316000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis).
    Nicoletti R; Ferranti P; Caira S; Misso G; Castellano M; Di Lorenzo G; Caraglia M
    World J Microbiol Biotechnol; 2014 Mar; 30(3):1047-52. PubMed ID: 24132497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
    Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
    J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligomeric acylphloroglucinols from myrtle (Myrtus communis).
    Appendino G; Bianchi F; Minassi A; Sterner O; Ballero M; Gibbons S
    J Nat Prod; 2002 Mar; 65(3):334-8. PubMed ID: 11908974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
    Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of Molecular Properties that Influence the Permeability and Oral Bioavailability of Major β-Boswellic Acids.
    Sharma T; Jana S
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):243-255. PubMed ID: 31786725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.
    Rådmark O; Samuelsson B
    J Intern Med; 2010 Jul; 268(1):5-14. PubMed ID: 20497297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structures and Bioactive Properties of Myrtucommulones and Related Acylphloroglucinols from Myrtaceae.
    Nicoletti R; Salvatore MM; Ferranti P; Andolfi A
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30572614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of the oligomeric acylphloroglucinols from Myrtus communis on cholesterol and human low density lipoprotein oxidation.
    Rosa A; Melis MP; Deiana M; Atzeri A; Appendino G; Corona G; Incani A; Loru D; Dessì MA
    Chem Phys Lipids; 2008 Sep; 155(1):16-23. PubMed ID: 18498764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.